1. Home
  2. DRVN vs RAPP Comparison

DRVN vs RAPP Comparison

Compare DRVN & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$13.05

Market Cap

2.0B

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$36.10

Market Cap

1.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRVN
RAPP
Founded
1972
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
DRVN
RAPP
Price
$13.05
$36.10
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$18.33
$48.50
AVG Volume (30 Days)
1.5M
288.5K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
146.70
24.34
EPS
0.85
N/A
Revenue
$1,862,438,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.53
N/A
P/E Ratio
$15.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.80
$10.57
52 Week High
$19.74
$42.27

Technical Indicators

Market Signals
Indicator
DRVN
RAPP
Relative Strength Index (RSI) 47.11 47.28
Support Level $12.49 $25.48
Resistance Level $13.54 $41.18
Average True Range (ATR) 0.59 1.93
MACD -0.11 -0.31
Stochastic Oscillator 27.69 30.01

Price Performance

Historical Comparison
DRVN
RAPP

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

Share on Social Networks: